Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2022

The advance of machines for drug delivery – scary? Or just another team member?

Session 01ME3 – Machines for drug delivery: change will happen, resistance is futile

Today Monday, June 6, 0930-1030H, Amber Room

Today’s final morning of Euroanaesthesia 2022 sees the often-controversial topic of automation addressed by Professor Michel Struys of University Medical Center Groningen, Netherlands. He will address all of your concerns – both the open and hidden ones – and confront the biggest factor that is slowing the advance of automation – regulation.

When looking at the impact of any drug, whether it is administered intravenously, intranasally or orally, the concentrations of the drug in the blood plasma will rise, before it moves on to the ‘effect site’ and couples with receptors, causing the ‘clinical effect’. “Automation can be added to measure and control any of these steps – indeed, the technology already exists to do it, so what is holding us back?  Two major things – regulation and trust in the technology from us the clinicians,” says Prof Struys.

“In fields such as fluid management and haemodynamic control, the medical world is almost ‘ready-to-go’,” he explains. “Medical experts will watch carefully as these technologies are approved and rolled out in hospitals worldwide. However, a never-ending list of regulatory hurdles is preventing the commercialisation of automated closed-loop drug delivery in total intravenous anaesthesia. But many of us believe that automation should be taking its rightful place as just another member of the medical team ensuring the best possible outcome for patients.”

The requirements of the US Food and Drug Administration (FDA) and the European Medicines Agency (through its Medical Device Regulations) are making the cost-benefit analysis for the progression of this technology in, for example, closed-loop anaesthesia, currently impossible. “There are also issues linked specifically to anaesthesia, such as how to better link (processed) electroencephalographic readings with the cerebral drug effects,” explains Prof Struys. “As technology and science advances, better algorithms will be developed and confidence in the technology will increase.”

Prof Struys believes that once medical teams see automated technology successfully manage fluid management and haemodynamic control, they will be much more willing to incorporate automation in many (most) of the procedures connected with anaesthesia and analgesia. In terms of commercial profitability, some closed loop systems such as those used in diabetes are already on the market and profitable due to high demand from the huge and growing population with diabetes demanding such technology. But for now, closed-loop anaesthesia drug delivery remains just out of reach, even as we know that in other areas of life – for example, the autopilots used in commercial aviation – acceptance and appreciation of this technology happened long ago.

Prof Struys will also discuss that another possible outcome as this technology develops is a ‘hybrid’ system in which the physician gets final approval of any solution suggested by automated drug delivery. “Imagine a situation for example where a patient develops severe hypotension – the closed loop anaesthesia technology will suggest a solution and prepare an intervention – but this will effectively be advice, and the doctor would have to approve or reject this advice and be ready to explain their decision afterwards.”

Please join Professor Struys for today’s session as he navigates the ethical, technological, and regulatory issues that swirl around the ever-advancing field of automation.

Read More of our special newsletter covering our congress.